Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:267-272

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubey, R. K.
Right arrow Articles by Jackson, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubey, R. K.
Right arrow Articles by Jackson, E. K.
Related Collections
Right arrow Remodeling
Right arrow Smooth muscle proliferation and differentiation
Right arrow Coronary circulation
Right arrow Receptor pharmacology
Right arrow Mechanism of atherosclerosis/growth factors

(Hypertension. 2000;35:267.)
© 2000 American Heart Association, Inc.


Scientific Contributions

A2B Receptors Mediate Antimitogenesis in Vascular Smooth Muscle Cells

Raghvendra K. Dubey; Delbert G. Gillespie; Holly Shue; Edwin K. Jackson

From the Departments of Medicine (R.K.D., D.G.G., E.K.J.) and Pharmacology (H.S., E.K.J.), Center for Clinical Pharmacology, University of Pittsburgh Medical Center (Pa), and Clinic for Endocrinology, Department of Obstetrics and Gynecology, University Hospital Zurich (Switzerland) (R.K.D.).

Correspondence to Dr Raghvendra K. Dubey, Center for Clinical Pharmacology, 623 Scaife Hall, 200 Lothrop St, University of Pittsburgh Medical Center, Pittsburgh, PA 15213-2582. E-mail dubey{at}med1.dept-med.pitt.edu

Abstract—Adenosine inhibits growth of vascular smooth muscle cells. The goals of this study were to determine which adenosine receptor subtype mediates the antimitogenic effects of adenosine and to investigate the signal transduction mechanisms involved. In rat aortic vascular smooth muscle cells, platelet-derived growth factor–BB (PDGF-BB) (25 ng/mL) stimulated DNA synthesis ([3H]thymidine incorporation), cellular proliferation (cell number), collagen synthesis ([3H]proline incorporation), total protein synthesis ([3H]leucine incorporation), and mitogen-activated protein (MAP) kinase activity. The adenosine receptor agonists 2-chloroadenosine and 5'-N-methylcarboxamidoadenosine, but not N6-cyclopentyladenosine or CGS21680, inhibited the growth effects of PDGF-BB, an agonist profile consistent with an A2B receptor–mediated effect. The adenosine receptor antagonists KF17837 and 1,3-dipropyl-8-p-sulfophenylxanthine, but not 8-cyclopentyl-1,3-dipropylxanthine, blocked the growth-inhibitory effects of 2-chloroadenosine and 5'-N-methylcarboxamidoadenosine, an antagonist profile consistent with an A2 receptor–mediated effect. Antisense, but not sense or scrambled, oligonucleotides to the A2B receptor stimulated basal and PDGF-induced DNA synthesis, cell proliferation, and MAP kinase activity. Moreover, the growth-inhibitory effects of 2-chloroadenosine, 5'-N-methylcarboxamidoadenosine, and erythro-9-(2-hydroxy-3-nonyl) adenine plus iodotubericidin (inhibitors of adenosine deaminase and adenosine kinase, respectively) were abolished by antisense, but not scrambled or sense, oligonucleotides to the A2B receptor. Our findings strongly support the hypothesis that adenosine causes inhibition of vascular smooth muscle cell growth by activating A2B receptors coupled to inhibition of MAP kinase activity. Pharmacological or molecular biological activation of A2B receptors may prevent vascular remodeling associated with hypertension, atherosclerosis, and restenosis following balloon angioplasty.


Key Words: adenosine • muscle, smooth • receptors, adenosine • vascular remodeling • hyperplasia




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. A. Auchampach, L. M. Kreckler, T. C. Wan, J. E. Maas, D. van der Hoeven, E. Gizewski, J. Narayanan, and G. E. Maas
Characterization of the A2B Adenosine Receptor from Mouse, Rabbit, and Dog
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 2 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu, K. Ravid, and B. D. Smith
Major Histocompatibility Class II Transactivator Expression in Smooth Muscle Cells from A2b Adenosine Receptor Knock-out Mice: CROSS-TALK BETWEEN THE ADENOSINE AND INTERFERON-{gamma} SIGNALING
J. Biol. Chem., May 23, 2008; 283(21): 14213 - 14220.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Shen and P. E. DiCorleto
Adenosine Prompts the Heart to Recruit Endothelial Progenitors
Circ. Res., February 15, 2008; 102(3): 280 - 282.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Yang, M. Koupenova, D. J. McCrann, K. J. Kopeikina, H. M. Kagan, B. M. Schreiber, and K. Ravid
The A2b adenosine receptor protects against vascular injury
PNAS, January 15, 2008; 105(2): 792 - 796.
[Abstract] [Full Text] [PDF]


Home page
Clin TrialsHome page
B. S Dixon, G. J Beck, L. M Dember, T. A Depner, J. J Gassman, T. Greene, J. Himmelfar, L. G Hunsicker, J. S Kaufman, J. H Lawson, et al.
Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial
Clinical Trials, October 1, 2005; 2(5): 400 - 412.
[Abstract] [PDF]


Home page
Circ. Res.Home page
J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden
Cell-Signaling Evidence for Adenosine Stimulation of Coronary Smooth Muscle Proliferation via the A1 Adenosine Receptor
Circ. Res., September 16, 2005; 97(6): 574 - 582.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson
Adenosine Inhibits PDGF-Induced Growth of Human Glomerular Mesangial Cells Via A2B Receptors
Hypertension, September 1, 2005; 46(3): 628 - 634.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. P. H. Leung, R. Y. K. Man, and C.-M. Tse
D-Glucose upregulates adenosine transport in cultured human aortic smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2756 - H2762.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden
Novel Mitogenic Effect of Adenosine on Coronary Artery Smooth Muscle Cells: Role for the A1 Adenosine Receptor
Circ. Res., May 13, 2005; 96(9): 982 - 990.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Feoktistov, S. Ryzhov, H. Zhong, A. E. Goldstein, A. Matafonov, D. Zeng, and I. Biaggioni
Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A2B Angiogenic Phenotype
Hypertension, November 1, 2004; 44(5): 649 - 654.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. P. Riksen, G. A. Rongen, H. J. Blom, F. G.M. Russel, G. H.J. Boers, and P. Smits
Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia
Cardiovasc Res, August 1, 2003; 59(2): 271 - 276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M.-C. Michoud, G. Napolitano, K. Maghni, V. Govindaraju, A. Cogo, and J. G. Martin
Effects of Extracellular Triphosphate Nucleotides and Nucleosides on Airway Smooth Muscle Cell Proliferation
Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. S. Ostrom, X. Liu, B. P. Head, C. Gregorian, T. M. Seasholtz, and P. A. Insel
Localization of Adenylyl Cyclase Isoforms and G Protein-Coupled Receptors in Vascular Smooth Muscle Cells: Expression in Caveolin-Rich and Noncaveolin Domains
Mol. Pharmacol., November 1, 2002; 62(5): 983 - 992.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson, C. Zhu, and S. P. Tofovic
Expression of adenosine receptors in the preglomerular microcirculation
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F41 - F51.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson and R. K. Dubey
Role of the extracellular cAMP-adenosine pathway in renal physiology
Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. J. Mundell, M. E. Olah, R. A. Panettieri Jr., J. L. Benovic, and R. B. Penn
Regulation of G Protein-Coupled Receptor-Adenylyl Cyclase Responsiveness in Human Airway Smooth Muscle by Exogenous and Autocrine Adenosine
Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 155 - 163.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. J. Rubin, L. R. Johnson, J. R. Dodam, A. K. Dhalla, L. Magliola, M. H. Laughlin, and A. W. Jones
Selective transport of adenosine into porcine coronary smooth muscle
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1397 - H1410.
[Abstract] [Full Text] [PDF]